GovBidAlerts
← All opportunities
This notice has been superseded. See the latest notice: Quetiapine Fumarate XR Tablets (Award Notice)

Quetiapine Fumarate XR Tablets

Key dates

Posted
Sep 19, 2023
Response deadline
—
Archive date
Oct 17, 2029
Archive type
autocustom

Classification

Notice type
Award Notice
Base type
Award Notice
Set-aside
—
Set-aside code
—
PSC
6505

NAICS

Issuing office

Department
DEPT OF DEFENSE
Sub-tier
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Office code
—
Organization type
OFFICE
Office address
PHILADELPHIA, PA, 19111, USA

Place of performance

Street
—
Street 2
—
City
Hauppauge
State
NY
Zip
11788
Country
USA

Contacts

Description

Modification SPE2D223D0012 P00001 to change the price effective date from December 17, 2023 to October 18, 2023. Modification SPE2D223D0012 P00001 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Award SPE2D223D0012 Quetiapine Fumarate XR Tablets

Award

Number
SPE2D223D0012
Amount
$4,329,877.25
Date
Sep 7, 2023
Awardee
GOLDEN STATE MEDICAL SUPPLY INC Camarillo CA 93012 USA
UEI
—
Awardee address
—

Other notices in this solicitation

Similar open contracts

Metadata

Notice ID
a89a6e6a15d348f98a72af085fae6da0
Full path
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
Office code
—
Ingested
May 2, 2026
Updated
Jul 28, 2026